Cargando…
Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York
BACKGROUND: In 2021, Delta became the predominant SARS-CoV-2 variant worldwide. While vaccines have effectively prevented COVID-19 hospitalization and death, vaccine breakthrough infections increasingly occurred. The precise role of clinical and genomic determinants in Delta infections is not known,...
Autores principales: | Duerr, Ralf, Dimartino, Dacia, Marier, Christian, Zappile, Paul, Levine, Samuel, Francois, Fritz, Iturrate, Eduardo, Wang, Guiqing, Dittmann, Meike, Lighter, Jennifer, Elbel, Brian, Troxel, Andrea B., Goldfeld, Keith S., Heguy, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323230/ https://www.ncbi.nlm.nih.gov/pubmed/35906172 http://dx.doi.org/10.1016/j.ebiom.2022.104141 |
Ejemplares similares
-
Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New York
por: Duerr, Ralf, et al.
Publicado: (2021) -
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study
por: Duerr, Ralf, et al.
Publicado: (2023) -
Amplification Artifact in SARS-CoV-2 Omicron Sequences Carrying P681R Mutation, New York, USA
por: Heguy, Adriana, et al.
Publicado: (2022) -
Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City – from Alpha to Omicron
por: Dellicour, Simon, et al.
Publicado: (2023) -
Remdesivir resistance in transplant recipients with persistent COVID-19
por: Hogan, John I, et al.
Publicado: (2022)